Global Research Collaboration for Infectious Disease Preparedness

The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international initiative to anticipate and prepare for future threats from infectious diseases. GloPID-R is intended to be a means for facilitating communication and collaboration between its member bodies, as opposed to a funding or disaster response entity.{{Cite web|url=http://ec.europa.eu/health/eu_world/docs/ev_20140612_c05_en.pdf|title=Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)|access-date=2016-02-28|first=Irene|last=Plank|publisher= European Commission}} Its secretariat is funded by the European Union through its Horizon 2020 initiative.{{Cite web |title=European Commission : CORDIS : Projects & Results Service : Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) Secretariat |url=http://cordis.europa.eu/project/rcn/194065_en.html |url-status=live |archive-url=https://archive.today/20230129005438/https://cordis.europa.eu/project/id/643434 |archive-date=2023-01-29 |access-date=2016-02-23 |website=European Commission}}

History

GloPID-R was launched in February 2013 in Brussels, Belgium on the recommendation of the Heads of International Research Organizations (HIROs).{{Cite web |last=Kaushic |first=Charu |last2=Boily-Larouche |first2=Geneviève |date=2020-12-17 |title=Coordinating research on pandemic preparedness and rapid response |url=https://www.openaccessgovernment.org/coordinating-research-on-pandemic-preparedness-and-rapid-response/100415/ |url-status=live |archive-url=https://web.archive.org/web/20230501222616/https://www.openaccessgovernment.org/coordinating-research-on-pandemic-preparedness-and-rapid-response/100415/ |archive-date=2023-05-01 |access-date=2023-05-08 |website=Open Access Government |language=en-GB}}{{Cite web |title=Our milestones – Global research collaboration for infectious disease preparedness |url=https://www.glopid-r.org/our-milestones/ |url-status=live |archive-url=https://web.archive.org/web/20230330005500/https://www.glopid-r.org/our-milestones/ |archive-date=2023-03-30 |access-date=2023-05-08 |website=Global Research Collaboration for Infectious Disease Preparedness}}

On February 11–12, 2020, GloPID-R co-hosted an event with the World Health Organization's R&D Blueprint called “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap”.{{Cite web |date=2020-02-06 |title=Global research and innovation forum to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency |url=https://www.who.int/news-room/events/detail/2020/02/11/default-calendar/global-research-and-innovation-forum-to-mobilize-international-action-in-response-to-the-novel-coronavirus-(2019-ncov)-emergency |url-status=live |archive-url=https://web.archive.org/web/20220718031653/https://www.who.int/news-room/events/detail/2020/02/11/default-calendar/global-research-and-innovation-forum-to-mobilize-international-action-in-response-to-the-novel-coronavirus-(2019-ncov)-emergency |archive-date=2022-07-18 |access-date=2023-02-09 |website=World Health Organization |language=en}} Participants in this conference identified a number of key research priorities which served as the basis on which funding decisions were made in response to the COVID-19 pandemic.{{Cite web |last=Kaushic |first=Charu |date=2020-03-26 |title=Message from the Scientific Director: The CIHR response to the COVID-19 pandemic - CIHR |url=https://cihr-irsc.gc.ca/e/51925.html |url-status=live |archive-url=https://archive.today/20230501221055/https://cihr-irsc.gc.ca/e/51925.html |archive-date=2023-05-01 |access-date=2023-05-08 |website=Canadian Institutes of Health Research}}

__TOC__

Membership

GloPID-R's membership is made up of national research funding agencies, academic research institutes and philanthropic organizations. The World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and European and Developing Countries Clinical Trials Partnership (EDCCTP) serve as observers.

{{As of|2023|2}}, GloPID-R's member organizations were as follows:{{cite web |title=Members |url=http://www.glopid-r.org/about-us/members/ |url-status=live |archive-url=https://web.archive.org/web/20221207110048/https://www.glopid-r.org/members/ |archive-date=2022-12-07 |access-date=2016-02-28 |website=GLOPID-R}}

class="wikitable" \|+Members and Representatives
Organization !Representative !Nation
Academy of Scientific Research & Technology \|Amr Radwan \|Egypt
African Academy of Sciences \|Thomas Kariuki \|Kenya
ANRS Emerging Infectious Diseases \|Yazdan Yazdanpanah \|France
Bill & Melinda Gates Foundation \|David W. Vaughn \|United States
Butantan Institute \|Alexander Precioso \|Brazil
Canadian Institutes of Health Research \|Charu Kaushic \|Canada
Carlos III Health Institute \|Tomás López-Peña \|Spain
Coalition for Epidemic Preparedness Innovations \|Richard Hatchett, Frederik Kristensen \|Global
United States Department of Health and Human Services \|Chris Hassell \|United States
ESSENCE on Health Research Initiative \|Garry Aslanyan \|Global
European and Developing Countries Clinical Trials Partnership \|Pauline Beattie \|Global
European Commission \|Barbara Kerstiens \|European Union
European Research Infrastructure on Highly Pathogenic Agents \|Jonathan Ewbank \|European Union
Instituto Fiocruz \|Marco Krieger \|Brazil
National Research and Innovation Fund for Development (FONRID) \|Hamidou H. Tamboura \|Burkina Faso
Fund for Science, Technology and Innovation (FONSTI) \|Annette Ouattara \|Côte-d'Ivoire
Foreign, Commonwealth and Development Office \|Jo Mulligan \|United Kingdom
Gavi, the Vaccine Alliance \|Marta Tufet-Bayona \|Global
Federal Ministry of Education and Research \|Manuela Rehtanz \|Germany
Global Outbreak Alert and Response Network \|Gail Carson \|Global
International Development Research Centre \|Samiran Panda \|Canada
Japan Agency for Medical Research and Development \|Shoji Miyagawa \|Japan
Medical Research Council (MRC) \|Anna Kinsey \|United Kingdom
Italian Ministry of Health \|Gaetano Guglielmi \|Italy
National Council for Science and Technology \|Eugène Mutimura \|Rwanda
National Council of Science and Technology (CONACYT) \|Juan José Serrato \|Mexico
National Health and Medical Research Council \|Anne Kelso \|Australia
Thai National Institute of Health \|Aree Thattiyaphong \|Thailand
National Research Foundation of Korea \|Choong-Min Ryu \|South Korea
Netherlands Organisation for Health Research and Development (ZONMW) \|Suzanne Verver \|Netherlands
Pasteur Network \|Nadia Khelef \|France
Research Council of Norway \|Thomas Hansteen \|Norway
São Paulo Research Foundation \|Rui Maciel \|Brazil
Secretariat of Government of Science, Technology and Productive Innovation \|Diego Galeano \|Argentina
South African Medical Research Council \|Jeffrey Mphahlele \|South Africa
Swiss National Science Foundation \|Matthias Egger \|Switzerland
Department of Health and Social Care \|Lucy Chappell \|United Kingdom
Wellcome Trust \|Jeremy Farrar \|United Kingdom
World Health Organization \|Ana-Maria Henao-Restrepo \|Global

class="wikitable"

|+Members and Representatives

Organization

!Representative

!Nation

Academy of Scientific Research & Technology

|Amr Radwan

|Egypt

African Academy of Sciences

|Thomas Kariuki

|Kenya

ANRS Emerging Infectious Diseases